GPT Healthcare Ltd (GPTHEALTH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039176,
    "name": "GPT Healthcare",
    "stock_name": "GPT Healthcare",
    "full_name": "GPT Healthcare Ltd",
    "name_url": "stocks-analysis/gpt-healthcare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "128.85",
    "chg": 0.85,
    "chgp": "0.66%",
    "dir": 1,
    "prev_price": "128.00",
    "mcapval": "1,031.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544131,
    "symbol": "GPTHEALTH",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE486R01017",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "3.92 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/gpt-healthcare-10039176-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "GPT Healthcare Sees Revision in Market Evaluation Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gpt-healthcare-downgraded-to-sell-by-marketsmojo-amid-weak-financials-and-bearish-technicals-3737129",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GPTHealthcare_mojoScore_3737129.png",
        "date": "2025-11-30 10:24:43",
        "description": "GPT Healthcare's market evaluation has undergone a revision reflecting shifts in its financial and technical outlook. The recent assessment highlights a complex interplay of factors including valuation appeal, operational challenges, and market sentiment within the hospital sector."
      },
      {
        "title": "How has been the historical performance of GPT Healthcare?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-gpt-healthcare-3683758",
        "imagepath": "",
        "date": "2025-11-09 22:49:52",
        "description": "Answer:\nThe historical performance of GPT Healthcare shows significant growth from March 2021 to March 2022.\n\nBreakdown:\nIn the fiscal year ending March 2022, GPT Healthcare reported net sales of 337.42 Cr, an increase from 242.75 Cr in the previous year. The total operating income also rose to 337.42 Cr from 242.75 Cr. Total expenditure, excluding depreciation, increased to 263.58 Cr from 193.76 Cr, driven by higher raw material costs and employee expenses. Operating profit, excluding other income, improved to 73.84 Cr from 48.99 Cr, leading to an operating profit margin of 21.88%, up from 20.18%. Profit before tax surged to 54.08 Cr from 28.88 Cr, resulting in a profit after tax of 41.66 Cr, compared to 21.09 Cr the previous year, reflecting a PAT margin increase to 12.35% from 8.69%. On the balance sheet, total liabilities grew to 319.51 Cr from 310.61 Cr, while shareholder's funds increased to 158.18 Cr..."
      },
      {
        "title": "Are GPT Healthcare latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-gpt-healthcare-latest-results-good-or-bad-3683345",
        "imagepath": "",
        "date": "2025-11-09 19:16:20",
        "description": "GPT Healthcare's latest financial results for Q2 FY26 reveal a complex operational landscape characterized by significant revenue growth alongside notable profitability challenges. The company reported net sales of ₹118.91 crores, marking an 11.02% increase compared to the previous quarter and a 12.54% rise year-on-year. This growth indicates the company's ability to scale its operations and enhance patient volumes across its hospital network.\n\nHowever, the profitability metrics present a stark contrast. The net profit for the quarter was ₹10.60 crores, reflecting a decline of 28.48% year-on-year and a decrease of 28.49% compared to the previous quarter. This decline in net profit is indicative of underlying operational difficulties, particularly in managing costs. The PAT margin contracted significantly to 8.91%, down from 14.03% in the same quarter last year, highlighting a concerning trend of margin comp..."
      },
      {
        "title": "GPT Healthcare Q2 FY26: Profit Slump and Margin Squeeze Raise Concerns Despite Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/gpt-healthcare-q2-fy26-profit-slump-and-margin-squeeze-raise-concerns-despite-revenue-growth-3682523",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GPTHealthcare_quaterlyResult_3682523.png",
        "date": "2025-11-08 18:03:05",
        "description": "GPT Healthcare Ltd., a small-cap hospital operator with a market capitalisation of ₹1,195 crores, reported a concerning decline in profitability for Q2 FY26, despite posting its highest-ever quarterly revenue. Net profit fell 28.49% quarter-on-quarter to ₹10.60 crores, whilst declining 28.48% year-on-year from ₹14.82 crores in Q2 FY25. The stock, trading at ₹147.35 as of November 7, 2025, has struggled throughout the year, declining 19.39% year-to-date and underperforming both the benchmark Sensex and its hospital sector peers by significant margins."
      },
      {
        "title": "Is GPT Healthcare technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-gpt-healthcare-technically-bullish-or-bearish-3674681",
        "imagepath": "",
        "date": "2025-11-06 08:32:05",
        "description": "As of 4 November 2025, the technical trend for GPT Healthcare has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include the bearish MACD on the weekly time frame, bearish signals from the Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily time frame. The stock has also shown negative returns year-to-date and over the past year compared to the Sensex, reinforcing the bearish outlook...."
      },
      {
        "title": "GPT Healthcare Faces Bearish Technical Trends Amid Market Volatility and Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gpt-healthcares-technical-trend-changes-from-mildly-bearish-to-bearish-amid-stock-price-decline-3674822",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GPTHealthcare_technicaldot_3674822.png",
        "date": "2025-11-06 08:21:09",
        "description": "GPT Healthcare, a small-cap hospital industry player, has recently revised its evaluation amid market challenges. The stock has experienced a year-long decline, contrasting with broader market gains. Technical indicators suggest a bearish sentiment, while the stock has shown stability over the past month despite significant volatility in its 52-week range."
      }
    ],
    "total": 273,
    "sid": "10039176",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/gpt-healthcare-10039176"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "27-Jan-2026",
      "details": "Please find enclosed intimation to discuss the financial performance of the Company on the Un-Audited Financial Results for the 3rd quarter and nine months (Q3 & 9MFY26) ended December 31 2025scheduled to be held on Tuesday February 3 2026 at 10.00 A.M (IST).",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Along With Limited Review Report Of The Statutory Auditors Thereon Of The Company For The 3Rd Quarter And Nine Months (Q3 & 9MFY26) Ended December 31 2025.",
      "datetime": "27-Jan-2026",
      "details": "GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 inter alia to consider and approve the Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon of the Company for the 3rd quarter and nine months (Q3 & 9MFY26) ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jan-2026",
      "details": "Please find enclosed herewith certificate under Regulation 74(5) of SEBI (DP) Regulations 2018.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "GPT Healthcare Ltd has declared <strong>10%</strong> dividend, ex-date: 14 Nov 25",
          "dt": "2025-11-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

GPT Healthcare Sees Revision in Market Evaluation Amidst Challenging Financial Trends

2025-11-30 10:24:43

GPT Healthcare's market evaluation has undergone a revision reflecting shifts in its financial and technical outlook. The recent assessment highlights a complex interplay of factors including valuation appeal, operational challenges, and market sentiment within the hospital sector.

How has been the historical performance of GPT Healthcare?

2025-11-09 22:49:52

Answer: The historical performance of GPT Healthcare shows significant growth from March 2021 to March 2022. Breakdown: In the fiscal year ending March 2022, GPT Healthcare reported net sales of 337.42 Cr, an increase from 242.75 Cr in the previous year. The total operating income also rose to 337.42 Cr from 242.75 Cr. Total expenditure, excluding depreciation, increased to 263.58 Cr from 193.76 Cr, driven by higher raw material costs and employee expenses. Operating profit, excluding other income, improved to 73.84 Cr from 48.99 Cr, leading to an operating profit margin of 21.88%, up from 20.18%. Profit before tax surged to 54.08 Cr from 28.88 Cr, resulting in a profit after tax of 41.66 Cr, compared to 21.09 Cr the previous year, reflecting a PAT margin increase to 12.35% from 8.69%. On the balance sheet, total liabilities grew to 319.51 Cr from 310.61 Cr, while shareholder's funds increased to 158.18 Cr...

Are GPT Healthcare latest results good or bad?

2025-11-09 19:16:20

GPT Healthcare's latest financial results for Q2 FY26 reveal a complex operational landscape characterized by significant revenue growth alongside notable profitability challenges. The company reported net sales of ₹118.91 crores, marking an 11.02% increase compared to the previous quarter and a 12.54% rise year-on-year. This growth indicates the company's ability to scale its operations and enhance patient volumes across its hospital network. However, the profitability metrics present a stark contrast. The net profit for the quarter was ₹10.60 crores, reflecting a decline of 28.48% year-on-year and a decrease of 28.49% compared to the previous quarter. This decline in net profit is indicative of underlying operational difficulties, particularly in managing costs. The PAT margin contracted significantly to 8.91%, down from 14.03% in the same quarter last year, highlighting a concerning trend of margin comp...

GPT Healthcare Q2 FY26: Profit Slump and Margin Squeeze Raise Concerns Despite Revenue Growth

2025-11-08 18:03:05

GPT Healthcare Ltd., a small-cap hospital operator with a market capitalisation of ₹1,195 crores, reported a concerning decline in profitability for Q2 FY26, despite posting its highest-ever quarterly revenue. Net profit fell 28.49% quarter-on-quarter to ₹10.60 crores, whilst declining 28.48% year-on-year from ₹14.82 crores in Q2 FY25. The stock, trading at ₹147.35 as of November 7, 2025, has struggled throughout the year, declining 19.39% year-to-date and underperforming both the benchmark Sensex and its hospital sector peers by significant margins.

Is GPT Healthcare technically bullish or bearish?

2025-11-06 08:32:05

As of 4 November 2025, the technical trend for GPT Healthcare has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include the bearish MACD on the weekly time frame, bearish signals from the Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily time frame. The stock has also shown negative returns year-to-date and over the past year compared to the Sensex, reinforcing the bearish outlook....

GPT Healthcare Faces Bearish Technical Trends Amid Market Volatility and Challenges

2025-11-06 08:21:09

GPT Healthcare, a small-cap hospital industry player, has recently revised its evaluation amid market challenges. The stock has experienced a year-long decline, contrasting with broader market gains. Technical indicators suggest a bearish sentiment, while the stock has shown stability over the past month despite significant volatility in its 52-week range.

View All News